HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Myelopathy in patients with antiphospholipid antibodies: clinical features, pathogenesis, and review of literature].

Abstract
We report 5 patients with anti-cardiolipin IgM-positive myelopathy. The lengths of spinal lesions were over two vertebral segments in 4 patients. Four cases showed subacute onset, and 2 out of these 4 cases had inflammatory changes in cerebrospinal fluid (CSF), and all of their symptoms improved. However, in one patient who showed an acute onset and normal findings of CSF, neurological symptoms did not improve. Three patients fulfilled the diagnostic criteria of primary antiphospholipid antibody syndrome. As for the pathophysiology of myelitis associated with antiphospholipid antibodies (aPL), it is suggested that vascular thrombosis affecting the blood cord barrier promotes an inflammatory changes. The heterogeneous CFS findings seem to reflect the difference in the intensity of inflammation. Both vascular thrombosis and inflammatory process should be considered as pathogenesis of these patients. Alone or combination therapy of steroids and anticoagulants might be effective in patients of myelopathy associated with APS.
AuthorsYukiko Tsutsumi, Atsuko Mochizuki, Keiko Maruyama, Shinichiro Uchiyama, Makoto Iwata
JournalRinsho shinkeigaku = Clinical neurology (Rinsho Shinkeigaku) Vol. 44 Issue 10 Pg. 655-60 (Oct 2004) ISSN: 0009-918X [Print] Japan
PMID15568479 (Publication Type: Case Reports, English Abstract, Journal Article, Review)
Chemical References
  • Antibodies, Antiphospholipid
  • Immunoglobulin M
Topics
  • Adult
  • Aged
  • Antibodies, Antiphospholipid (analysis)
  • Antiphospholipid Syndrome (diagnosis)
  • Diagnosis, Differential
  • Female
  • Humans
  • Immunoglobulin M (analysis)
  • Magnetic Resonance Imaging
  • Middle Aged
  • Myelitis (etiology, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: